Skip to main content

Table 2 Assessment of risk of bias in the included studies using Cochrane criteria

From: Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Study

Reference

Sequence generation

Allocation concealment

Blinding of participants and personnel

Blinding of outcome assessment

Incomplete outcome data

Selective outcome reporting

Other potential threats to validity

Eshtehardi et al. 2012

[21]

H

H

H

H

L

L

L

Guo et al. 2012

[22]

U

U

H

H

L

L

L

Hong et al. 2009

[23]

U

U

H

H

L

L

L

Hwang et al. 2013

[24]

H

H

H

L

L

L

H

Lee et al. 2012

[14]

L

L

L

L

L

L

L

Nasu et al. 2009

[25]

H

H

H

H

L

L

L

Nozue et al. 2012

[26]

L

L

H

L

L

L

L

Puri et al. 2014

[27]

U

U

H

H

L

L

L

Taguchi et al. 2013

[28]

H

H

H

H

L

L

L

  1. H, high risk of bias; L, low risk of bias; U, unclear risk of bias